NL-OMON41806已完成不适用
Pharmacodynamic breakpoints for ciprofloxacin efficacy and resistance in critically ill patients treated with continuous venovenous hemodialysis: a prospective case series study. - Ciprofloxacin pharmacodynamics in ICU-patients on CVVHD
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Admission to the ICU of the Zaandam Medical Center during the study period
- •Expected to be undergoing CVVHD for >24 h
- •Treatment with ciprofloxacin for any infection or suspected infection, as judged by the attending physician.
- •Age >= 18 years
排除标准
- •Cessation of renal replacement therapy before obtainment of a through sample
- •No CRRT delivered during >25 % of the interval between obtainment of peak and through plasma samples.
研究者
相似试验
已完成
不适用
To study ciprofloxacin pharmacokinetics in patients who are critically ill and undergoing continuous dialysisPatients on dialysisNutritional, Metabolic, EndocrineRenal failureISRCTN52722850Trinity College Dublin (Ireland)7
进行中（未招募）
不适用
Investigation of pharmacokinetics of Ciprofloxacin and Piperacillin/Tazobactam in Patients receiving continuous renal replacement therapyEUCTR2010-021369-66-DEDepartment of Pharmacy Universitaetsmedizin Mainz40
已完成
4 期
Examining whether any interactions occur between the antibiotic Ciprofloxacin and the antimalarial treatment Chloroquine/ProguanilPharmacokineticsISRCTN20647977Defence Science and Technology Laboratory (Dstl)16
进行中（未招募）
1 期
Pharmacokinetic Interactions between Ciprofloxacin and Chloroquine / Proguanil ProphylaxisChloroquine/proguanil is used for malaria chemoprophylaxis in areas where chloroquine-resistant Plasmodium falciparum malaria is prevalent, except in regions of Africa where chloroquine/proguanil is no longer effective. Ciprofloxacin is a fluoroquinolone antibiotic used to treat a wide variety of infections, such as traveller`s diarrhoea. Only healthy subjects will be treated in this study.EUCTR2005-004905-27-GBDstl16
已完成
不适用
A study of the concentration of ciprofloxacin in the body over time when given by mouthSevere acute malnutritionNutritional, Metabolic, EndocrineUnspecified protein-energy malnutritionISRCTN31079753Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme (Kenya)52